An update from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry on current activity in hematopoietic stem cell transplantation
- PMID: 9358995
- DOI: 10.1097/00062752-199704060-00006
An update from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry on current activity in hematopoietic stem cell transplantation
Abstract
The International Bone Marrow Transplant Registry (IBMTR) and the Autologous Blood and Marrow Transplant Registry (ABMTR) are international research organizations that collect and analyze data on recipients of allogeneic and autologous hematopoietic stem cell transplants, respectively. Over 300 institutions in 47 countries contribute data to the IBMTR and over 150 institutions in North and South America contribute data to the ABMTR. The IBMTR and ABMTR database have information on more than 65,000 transplant recipients, about 40% of allogeneic transplantations performed since 1964, and about half of all autotransplantations in North and South America since 1989. Current transplant activity, as reported to the IBMTR and ABMTR, is summarized in this article as well as key findings from recent IBMTR and ABMTR studies.
Similar articles
-
Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America.Clin Transpl. 1995:117-27. Clin Transpl. 1995. PMID: 8794259
-
Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry--North America.Clin Transpl. 1994:87-98. Clin Transpl. 1994. PMID: 7547596
-
Transplant registries: guiding clinical decisions and improving outcomes.Oncology (Williston Park). 2001 May;15(5):649-59; discussion 663-4, 666. Oncology (Williston Park). 2001. PMID: 11396358
-
Bone marrow transplantation--1994: a report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry.J Hematother. 1994 Summer;3(2):95-102. doi: 10.1089/scd.1.1994.3.95. J Hematother. 1994. PMID: 7922018 Review. No abstract available.
-
[Transplantation of hematopoietic stem cells].Internist (Berl). 1996 Mar;37(3):295-303. Internist (Berl). 1996. PMID: 8919947 Review. German. No abstract available.
Cited by
-
Busulfan and fludarabine conditioning regimen given at hematological nadir of cytoreduction fludarabine, cytarabine, and idarubicin chemotherapy in patients with refractory acute myeloid leukemia undergoing allogeneic stem cell transplantation: a single arm pilot consort study.Medicine (Baltimore). 2015 Apr;94(15):e706. doi: 10.1097/MD.0000000000000706. Medicine (Baltimore). 2015. PMID: 25881847 Free PMC article. Clinical Trial.
-
Treatment of intracranial nongerminomatous germ-cell tumor by high-dose chemotherapy and autologous stem-cell rescue.J Neurooncol. 1999 Aug;44(1):71-6. doi: 10.1023/a:1006395719917. J Neurooncol. 1999. PMID: 10582672
-
Successful neoadjuvant synchronous chemo- and radiotherapy for disseminated primary intracranial choriocarcinoma: case report.J Neurooncol. 2007 Jun;83(2):199-204. doi: 10.1007/s11060-006-9311-1. Epub 2007 Jan 5. J Neurooncol. 2007. PMID: 17205387
-
When Less Is Good, Is None Better? The Prognostic and Therapeutic Significance of Peri-Transplant Minimal Residual Disease Assessment in Pediatric Acute Lymphoblastic Leukemia.J Clin Med. 2017 Jul 7;6(7):66. doi: 10.3390/jcm6070066. J Clin Med. 2017. PMID: 28686179 Free PMC article. Review.
-
Salvage therapy for relapsed or refractory acute myeloid leukemia.Ther Adv Hematol. 2011 Apr;2(2):73-82. doi: 10.1177/2040620711402533. Ther Adv Hematol. 2011. PMID: 23556078 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical